Navigation Links
Alnylam and Stanford University Scientists Discover New Role for,microRNAs (miRNAs) in T Cell Biology and Immunity

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar 22, 2007 - Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today publication of a study in the journal Cell by Alnylam and Stanford University scientists on the role of miRNAs in immunity. In the pre-clinical study, a specific miRNA, miR-181a, was shown to play an important role in controlling T cell responsiveness to antigens by regulating the T cell receptor signaling pathway. Because the T cell response to antigens is one of the primary components of certain autoimmune disorders, these findings further validate miRNAs as disease targets and point to new potential therapeutic applications for antagomirs, a novel class of oligonucleotide-based inhibitors of specific miRNAs.

"Our research points to a critical role for miRNAs, specifically miR-181a, in the regulation of T cell biology," said Dr. Mark Davis from Stanford University School of Medicine, a senior author of the publication. "We're excited about this new discovery as it represents the first clear example of a role for miRNAs in the immune response to antigens."

"In our study, upward or downward modulation of miR-181a was found to control certain aspects of T cell development and to regulate T cell responses to antigens via the T cell receptor signaling pathway," said Dr. Chang-Zheng Chen, also from Stanford University School of Medicine and a senior author of the publication.

"Alnylam's research on miRNAs derives from our discovery of antagomirs, a novel class of oligonucleotide inhibitors of miRNAs. These reagents have become powerful tools to investigate the role of miRNAs in biology and disease processes. We are fortunate to collaborate with some of the leading labs across the world, such as our colleagues at Stanford, in our efforts to explore therapeutic opportunities for miRNA antagonists," said Dr. Muthiah Manoharan, Vice President, Drug Discovery
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Alnylam Reports Results of Human Experimental Infection Model with Respiratory Syncytial Virus
2. Alnylam Announces Advancement of a New RNAi Therapeutic Development Program for the Treatment of Liver Cancer
3. Stanford Researchers Find Brain Pathway of Depression in Rats
4. Common Preterm Labor Drug Has More Side Effects Than Alternative, Finds Study from Packard Childrens Hospital and Stanford
5. Stanford Researchers Track Human Stem Cells Transplanted Into Rat Brain
6. Once-Fatal Metabolic Disorders Treatable, Says Stanford/Packard Researcher
7. Limiting Eligibility for Medical Studies Can Omit Women, African-Americans, Stanford Study Finds
8. Fragile X, Down Syndromes Linked to Faulty Brain Communication, Stanford Researcher Finds
9. Stanford Study Finds No Conclusive Benefit From Treating Kleptomania With Medication
10. Study of Drug Therapy for Compulsive Buying Yields a Puzzle, Stanford Researcher Says
11. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
Post Your Comments:
(Date:1/15/2014)...  In an unprecedented effort to curb the spread of "superbugs" such ... vehicles, an advanced and portable UV germicidal lamp manufactured by MRSA-UV ... In order to prevent EMS paramedics and transport ... West Palm Beach Fire Rescue is the first in ...
(Date:1/15/2014)... MultiCell Technologies, Inc. (OTC Bulletin Board: MCET.OB ... composition of matter, biological targets, mechanism of action, methods ... This patent application describes a novel class ... which interfere with the basic homeostatic cellular processes in ...
(Date:1/15/2014)... , Jan. 15, 2014 The Cadence Fitness & ... Center by the Medical Fitness Association, a non-profit organization ... their full potential. The Cadence Fitness & Health Center ... suburbs and second in the Chicagoland area. ...
Breaking Medicine Technology:Superbugs No Longer Ride In Rescue Vehicles 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3
(Date:7/9/2014)... YORK (July 8, 2014) Researchers from Montefiore ... of Medicine of Yeshiva University will present new ... held July 12 July 17 in Copenhagen, Denmark. ... that could prompt transition from cognitive normality to mild ... the Einstein Aging Study , established in 1980 ...
(Date:7/9/2014)... for more than watching World Cup highlights, Brian Williams ... landing in unfortunate positions on railings. A University of ... Online Journal shows that YouTube also allows researchers, ... public on topics of skin cancer and prevention. , ... the future of how we communicate around the world," ...
(Date:7/9/2014)... Diseases (NIAID), part of the National Institutes of ... CRS3123, an investigational oral antibiotic intended to treat ... infection. CRS3123 (previously known as REP3123) is a ... sparing normal intestinal bacteria. , The Phase I ... and women ages 18 to 45 in a ...
(Date:7/9/2014)... 2014) A retrospective study conducted by researchers at ... that among adults with intellectual and developmental disabilities, the ... years receiving dental care increased. The findings, published in ... , may help improve interventions designed to address the ... The researchers reviewed the dental records of 107 patients ...
(Date:7/9/2014)... with kidney and heart disease have raised concerns about ... However, in the first study to look closely at ... at the University of Pennsylvania report that older kidney ... and cardiovascular health as very healthy older people who ... ever increasing organ transplant waitlists, the authors of the ...
Breaking Medicine News(10 mins):Health News:Investigators from Montefiore and Einstein to present data at 2014 Alzheimer's Association International Conference 2Health News:Investigators from Montefiore and Einstein to present data at 2014 Alzheimer's Association International Conference 3Health News:Study of dermatology on YouTube shows new ways science reaches public 2Health News:NIH launches Phase I clinical trial of novel drug to treat Clostridium difficile infection 2Health News:Adults with special needs see gains, challenges with long term oral care 2Health News:Adults with special needs see gains, challenges with long term oral care 3Health News:Penn study finds living kidney donation does not increase risk of death or heart disease for older 2
... Health Integrated, Inc., a,pioneer in health and condition ... its ground-breaking Synergy Personal Health,Management program at DMAA,s ... September 16th at Caesar,s Palace in Las,Vegas. ... a need to stay,informed of the best practices, ...
... is a prevailing issue in the United States, with ... study reveals that Pycnogenol, (pic-noj-en-all), an antioxidant plant extract ... reduces ADHD in children. The study shows Pycnogenol balances ... a decrease of ADHD. , The findings, to ...
... 12, 2007) For the first time in history, ... corals in its annual report of wildlife going extinct. ... Conservation International (CI) and implemented jointly with the IUCN ... Darwin Research Station and other regional institutions to conclude ...
... ReBuilder Medical,Technologies, Inc. today reported to its board ... base to include England, Canada, New,Zealand and Australia. ... sales began to come in as a result ... using the ReBuilder System(R). Through,word of mouth and ...
... Biomedical,Corporation (TSX-V: RBM, OTCBB: RPBIF) today announced the ... (CEO). Mr. Kay was also appointed,to the Company,s ... former President, CEO and Director of Quidel Corporation,a ... and,marketing of rapid diagnostic solutions at the point-of-care ...
... Md., Sept. 12 Since the late,1980,s, adult obesity has ... of all Americans are now overweight and over 30 percent ... to 19 are,overweight -- nearly double the rate of two ... is the Nutrition Facts Label on,food packages, according to the ...
Cached Medicine News:Health News:Health Integrated to Showcase Synergy Personal Health Management(R) at DMAA Conference 2Health News:New study: Pine bark extract reduces ADHD symptoms in children 2Health News:Corals added to IUCN Red List of Threatened Species for first time 2Health News:Corals added to IUCN Red List of Threatened Species for first time 3Health News:ReBuilder Medical Technologies, Inc. Reports International Sales Expansion 2Health News:ReBuilder Medical Technologies, Inc. Reports International Sales Expansion 3Health News:ReBuilder Medical Technologies, Inc. Reports International Sales Expansion 4Health News:Response Biomedical appoints S. Wayne Kay Chief Executive Officer 2Health News:Response Biomedical appoints S. Wayne Kay Chief Executive Officer 3Health News:Response Biomedical appoints S. Wayne Kay Chief Executive Officer 4Health News:FDA: Use the Nutrition Facts Label to Make Healthy Food Choices 2
... tilt, user programmable memory two position ... on both chair sides, solid cast ... Single button folding armrests and headrest, ... on both chair sides, ergonomically contoured ...
... chair for examination of the ... adjustable from 540 mm to ... an independent foot switch. The ... and incorporates a multi-adjustable headrest, ...
Heine Beta 200 Streak Retinoscope 3.5v w/Twist Lock for Welch-Allyn style handles....
Heine Beta 200 Streak Retinoscope 3.5v...
Medicine Products: